CNBX PHARMACEUTICALS INC. Increase (Decrease) in Deferred Revenue
CNBX PHARMACEUTICALS INC. (CNBX) reported Increase (Decrease) in Deferred Revenue of $0 for the 12-month period ending 2017-08-31, per its 10-K filed 2017-12-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2017-12-08
- CNBX PHARMACEUTICALS INC. increase (decrease) in deferred revenue for the quarter ending 2017-08-31 was $0.00.
- CNBX PHARMACEUTICALS INC. increase (decrease) in deferred revenue for the quarter ending 2016-08-31 was -$50.00K.
- CNBX PHARMACEUTICALS INC. increase (decrease) in deferred revenue for fiscal 2017 was $0.00.
- CNBX PHARMACEUTICALS INC. increase (decrease) in deferred revenue for fiscal 2016 was $0.00.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|
| 2017-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-08 | $0.00 10-K · filed 2017-12-08 | |
| 2017-05-31 | $0.00 10-Q · filed 2017-07-17 | ||
| 2016-08-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-08 | $0.00 10-K · filed 2017-12-08 | |
| 2016-05-31 | $50.00K 10-Q · filed 2017-07-17 | ||
| 2015-05-31 | $0.00 10-Q · filed 2016-07-13 |